222 related articles for article (PubMed ID: 35600594)
1. Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study.
Ha EY; Chung SM; Park IR; Lee YY; Choi EY; Moon JS
Front Endocrinol (Lausanne); 2022; 13():869451. PubMed ID: 35600594
[TBL] [Abstract][Full Text] [Related]
2. Effect of glycemic gap upon mortality in critically ill patients with diabetes.
Lou R; Jiang L; Zhu B
J Diabetes Investig; 2021 Dec; 12(12):2212-2220. PubMed ID: 34075715
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes.
Liao WI; Wang JC; Chang WC; Hsu CW; Chu CM; Tsai SH
Medicine (Baltimore); 2015 Sep; 94(36):e1525. PubMed ID: 26356728
[TBL] [Abstract][Full Text] [Related]
4. Association Between Glycemic Gap and Mortality in Critically Ill Patients with Diabetes.
Lou R; Jiang L; Wang M; Zhu B; Jiang Q; Wang P
J Intensive Care Med; 2023 Jan; 38(1):42-50. PubMed ID: 35611506
[TBL] [Abstract][Full Text] [Related]
5. Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes.
Shah VN; Vigers T; Pyle L; Calhoun P; Bergenstal RM
Diabetes Technol Ther; 2023 May; 25(5):324-328. PubMed ID: 36790875
[No Abstract] [Full Text] [Related]
6. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes.
Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Taori G; Hegarty C; Bailey M
Crit Care Med; 2011 Jan; 39(1):105-11. PubMed ID: 20975552
[TBL] [Abstract][Full Text] [Related]
7. Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia.
Kim SH; Kim JY; Kim ES; Park IR; Ha EY; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
Ann Med; 2022 Dec; 54(1):2736-2743. PubMed ID: 36205625
[TBL] [Abstract][Full Text] [Related]
8. The Glucose Management Indicator: Time to Change Course?
Selvin E
Diabetes Care; 2024 Jun; 47(6):906-914. PubMed ID: 38295402
[TBL] [Abstract][Full Text] [Related]
9. Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data.
Chrzanowski J; Michalak A; Łosiewicz A; Kuśmierczyk H; Mianowska B; Szadkowska A; Fendler W
Diabetes Technol Ther; 2021 Apr; 23(4):293-305. PubMed ID: 33112161
[No Abstract] [Full Text] [Related]
10. Effect of glycemic gap on short term outcome in critically ill patient: In zagazig university hospitals.
Fawzy F; Saad MSS; ElShabrawy AM; Eltohamy MM
Diabetes Metab Syndr; 2019; 13(2):1325-1328. PubMed ID: 31336486
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.
Toschi E; Michals A; Adam A; Davis D; Atakov-Castillo A; Slyne C; Munshi M
Diabetes Care; 2021 Dec; 44(12):2787-2789. PubMed ID: 34635503
[TBL] [Abstract][Full Text] [Related]
12. An Examination of the Glucose Management Indicator in Young Children with Type 1 Diabetes.
Monzon AD; Patton SR; Clements M
J Diabetes Sci Technol; 2022 Nov; 16(6):1505-1512. PubMed ID: 34098763
[TBL] [Abstract][Full Text] [Related]
13. Glycated hemoglobin at admission in the intensive care unit: clinical implications and prognostic relevance.
Kompoti M; Michalia M; Salma V; Diogou E; Lakoumenta A; Clouva-Molyvdas PM
J Crit Care; 2015 Feb; 30(1):150-5. PubMed ID: 25239822
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of glucose management indicator derived from continuous glucose monitoring to assess glycemic condition in hospitalized patients with diabetic kidney disease treated with insulin pumps.
Lu Y; Zhang Q; Wang X; Jiang Y; Xue Y
J Diabetes Complications; 2023 Nov; 37(11):108613. PubMed ID: 37769507
[TBL] [Abstract][Full Text] [Related]
15. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.
Oriot P; Viry C; Vandelaer A; Grigioni S; Roy M; Philips JC; Prévost G
J Diabetes Sci Technol; 2023 Nov; 17(6):1553-1562. PubMed ID: 35466719
[TBL] [Abstract][Full Text] [Related]
16. Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes.
Fang M; Wang D; Rooney MR; Echouffo-Tcheugui JB; Coresh J; Aurora RN; Punjabi NM; Selvin E
Clin Chem; 2023 Apr; 69(4):422-428. PubMed ID: 36738249
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes.
Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Maffeis C
Pediatr Diabetes; 2022 Feb; 23(1):84-89. PubMed ID: 34888998
[TBL] [Abstract][Full Text] [Related]
18. Differences in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit: a pilot study.
Lundelin K; Vigil L; Bua S; Gomez-Mestre I; Honrubia T; Varela M
Crit Care Med; 2010 Mar; 38(3):849-54. PubMed ID: 20068460
[TBL] [Abstract][Full Text] [Related]
19. [Impacts of glycemic variability on the relationship between time in range and estimated glycated hemoglobin in patients with type 1 diabetes mellitus].
Peng HM; Deng HR; Zhou YW; Wang CF; Lyu J; Mai XD; Yang DZ; Lu J; Xu W; Yan JH
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1190-1195. PubMed ID: 35462500
[No Abstract] [Full Text] [Related]
20. Glucose Management Indicator for People with Type 1 Asian Diabetes Is Different from That of the Published Equation: Differences by Glycated Hemoglobin Distribution.
Yoo JH; Yang SH; Kim G; Kim JH
Diabetes Technol Ther; 2021 Nov; 23(11):745-752. PubMed ID: 34160289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
